Share Search
Visit the Share Search
Bodycote to acquire Ellison Surface Technologies in ?154m deal
24th Dec 2019 07:40
(Sharecast News) - Heat treatment and specialist thermal processing services company Bodycote has entered into an agreement to acquire Ellison Surface Technologies, it announced on Tuesday, in a bid to create one of the world's largest providers of thermal spray and engineered coating surface technology services to the aerospace industry.
The FTSE 250 company said Ellison's business, based in North America, would be "highly complementary" to its existing Surface Technology business.
It said it was primarily focused on the aerospace market, and would be integrated into Bodycote's surface technology and aerospace business, which itself had seen "strong structural growth" in recent years.
Gross consideration for the acquisition would be $200m (£154m).
When adjusted for tax benefits worth at least £30m, net consideration for the transaction would be approximately £170m, and would be settled using Bodycote's existing committed credit facilities.
Ellison's business generated revenues of $50m in 2018, with associated pro-forma EBITDA of $8m.
Based on results for the year-to-date, it was expected that Ellison's revenue for 2019 would be $58m, with pro-forma EBITDA of $12m.
That expected revenue growth of 16%, and its associated 50% increase in pro-forma EBITDA, reflected the fact that Ellison had been successfully gaining share in the civil aviation business, which would also provide a "solid foundation" for further revenue and profit growth in future years, the Bodycote board said.
It was also expected that the Ellison business would be immediately earnings enhancing to the enlarged Bodycote business.
Ellison employs almost 400 people across six sites located across the United States, Canada and Mexico.
"Ellison's business is one that we have long respected and is a perfect strategic fit for Bodycote's aerospace and Specialist Technologies' businesses," said group chief executive officer Stephen Harris.
"Ellison has been successful in winning new business in recent years and it will be very complementary to Bodycote's existing Surface Technology business."
Completion of the transaction was contingent on various regulatory filings, and was expected to complete during the first quarter of 2020.
The FTSE 250 company said Ellison's business, based in North America, would be "highly complementary" to its existing Surface Technology business.
It said it was primarily focused on the aerospace market, and would be integrated into Bodycote's surface technology and aerospace business, which itself had seen "strong structural growth" in recent years.
Gross consideration for the acquisition would be $200m (£154m).
When adjusted for tax benefits worth at least £30m, net consideration for the transaction would be approximately £170m, and would be settled using Bodycote's existing committed credit facilities.
Ellison's business generated revenues of $50m in 2018, with associated pro-forma EBITDA of $8m.
Based on results for the year-to-date, it was expected that Ellison's revenue for 2019 would be $58m, with pro-forma EBITDA of $12m.
That expected revenue growth of 16%, and its associated 50% increase in pro-forma EBITDA, reflected the fact that Ellison had been successfully gaining share in the civil aviation business, which would also provide a "solid foundation" for further revenue and profit growth in future years, the Bodycote board said.
It was also expected that the Ellison business would be immediately earnings enhancing to the enlarged Bodycote business.
Ellison employs almost 400 people across six sites located across the United States, Canada and Mexico.
"Ellison's business is one that we have long respected and is a perfect strategic fit for Bodycote's aerospace and Specialist Technologies' businesses," said group chief executive officer Stephen Harris.
"Ellison has been successful in winning new business in recent years and it will be very complementary to Bodycote's existing Surface Technology business."
Completion of the transaction was contingent on various regulatory filings, and was expected to complete during the first quarter of 2020.